Xiangya Hospital Of Central South University
Clinical trials sponsored by Xiangya Hospital Of Central South University, explained in plain language.
-
Second chance for hepatitis c patients: new combo shows promise
Disease control OngoingThis study tests a 12-week course of three antiviral drugs (sofosbuvir, velpatasvir, voxilaprevir) in 200 adults with chronic hepatitis C whose infection returned after previous treatment. The main goal is to see if the virus becomes undetectable 12 weeks after therapy ends. Rese…
Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated May 26, 2026 05:23 UTC
-
New triple therapy targets hard-to-treat liver cancer
Disease control ENROLLING_BY_INVITATIONThis early-stage study tests whether adding two drugs (JS014 and Toripalimab) to a standard liver cancer procedure (TACE) is safe and helps control tumors. About 20 adults with liver cancer that cannot be removed by surgery will take part. The main goal is to check for side effec…
Phase: PHASE1 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated May 19, 2026 12:01 UTC